Skip to main content

Table 3 The comparison of variables in the control group (splint) at the beginning and end of study

From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Variables

Group

Number

Mean

SD

P value

VAS

Before

20

6.24

1.13

< 0.001

After

20

3.52

2.02

MedSNAP PL

Before

20

4.05

0.25

0.001

After

20

3.75

0.35

MedCMAP OL

Before

20

4.06

0.59

0.002

After

20

4.07

0.55

SSS

Before

20

2.76

0.40

< 0.001

After

20

1.90

0.42

FS

Before

20

2.54

0.63

< 0.001

After

20

1.82

0.42